Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...

Health-care companies fell as traders weighed risks in a wave of deal activity. Pfizer joined Big Pharma rivals hunting for novel weight loss drugs in the Chinese biotech sector.

Dow Jones Top Company Headlines at 5 PM ET: JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks May Have to Keep Up. | Nvidia ... JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks ...

The executive, who would expand the size of the board to a total of 11 members, will stand election at the media giant's 2026 annual meeting of shareholders ...

Jeff Williams, a former Apple executive, will stand for election as a new independent director of Disney at the 2026 annual ...

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...

A record-setting Mega Millions ticket worth more than $5.1 million was sold in California this week, marking one of the ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

Eli Lilly has broken free from the Big Pharma pack. Fueled by sky-high expectations for the GLP-1 market, Lilly has achieved a growth rate and valuation that have more in common with AI-fueled tech ...

(Reuters) -Eli Lilly is dropping CVS Health’s drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk, Bloomberg News ...

Eli Lilly & Co. is dropping CVS Health Corp ’s drug benefit plan for its employees after CVS stopped covering its blockbuster weight-loss drug in favor of a rival medication from Novo Nordisk A/S, ...

3. Don't overlook your health system pharmacy when it comes to applying innovation. See how a technology-driven medication management strategy can optimize outcomes — Learn more here.